Patent 11224364 was granted and assigned to PROGENITY, INC. on January, 2022 by the United States Patent and Trademark Office.
An ingestible device is disclosed which can produce spectral data of one or more analytes, as well as associated methods for characterizing the gastrointestinal tract of a subject which contains such analytes. Related kits and systems are also disclosed.